Advertisement

Topics

ANTARES PHARMA INC. Company Profile

01:01 EDT 24th September 2017 | BioPortfolio

The Antares Pharma, Inc. website contains information about products and technologies that may or may not be available in any particular country. Information on the website is not to be construed as a promotion or offer to sell any product in any country in which the product is not available. Information presented in the Antares Pharma website is subject to change and may become out of date over time. It is not intended to be a complete or exhaustive discussion of Antares Pharma products and technologies. The information presented is not a replacement for advice from a health care professional. Consumers should consult their physician or other health care professional for advice on medical matters

Location

707 Eagleview BoulevardSuite 414
Exton
19341
United States of America

Contact

Phone: 1 (610) 458 6200
Fax: 1 (610) 458 0756
Email: info@antarespharma.com


News Articles [2320 Associated News Articles listed on BioPortfolio]

Antares Pharma enters into $35mm term loan with Hercules Capital

Antares Pharma Inc. (parenteral pharmaceuticals) entered into a term loan with Hercules Capital in which it can receive up to $35mm in debt. The loan is available in two tranches with the first $25mm...

European Commission awards Antares Vision a grant for new technology

The European Commission (EC) has awarded Antares Vision, provider of serialisation-based track and trace solutions for the pharma industry, a grant for the development of new technology for the inspec...

Antares Pharma Reports 2Q Loss

NewsAntares Pharma Inc. on Tuesday reported a loss of $2.8 million in its second quarter.Contributed Author: 

Antares Pharma: Focus On Xyosted

Antares Pharma Announces Debt Financing From Hercules Capital

EWING, N.J., June 07, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that it has entered into a loan and security agreement for a term loan of up to $35 million, with...

Antares Pharma to Present at the Jefferies 2017 Healthcare Conference

EWING, N.J., June 01, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies 2017 H...

Antares Pharma Inc. 2017 Q2 - Results - Earnings Call Slides

Antares Pharma Inc. 2017 Q1 - Results - Earnings Call Slides

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [34 Associated PubMed Articles listed on BioPortfolio]

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Sperm whale long-range echolocation sounds revealed by ANTARES, a deep-sea neutrino telescope.

Despite dedicated research has been carried out to adequately map the distribution of the sperm whale in the Mediterranean Sea, unlike other regions of the world, the species population status is stil...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

AI-powered drug discovery captures pharma interest.

Clinical Trials [73 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [720 Associated Companies listed on BioPortfolio]

ANTARES PHARMA INC.

The Antares Pharma, Inc. website contains information about products and technologies that may or may not be available in any particular country. Information on the website is not to be construed as a...

Antares Pharma, Inc.

Antares Pharma focuses on self-injection delivery technologies and topical gel-based pharmaceutical products. The Company's subcutaneous and intramuscular injection technology pla...

Antares Pharma, Inc. and Population Council

Antares Pharma focuses on self-injection delivery technologies and topical gel-based pharmaceutical products. The Company’s subcutaneous injection technology platforms includ...

Antares

With over a decade of experience developing and building high-end I/O peripherals for Sun® and Intel based systems, the Antares Microsystems’ family of products provide versatile and flexible solut...

Antares Management Solutions

Antares Management Solutions is a market leader in providing Business Process Outsourcing (BPO) and Information Technology Outsourcing (ITO) services to insurance and other industries. The company's...

More Information about "ANTARES PHARMA INC." on BioPortfolio

We have published hundreds of ANTARES PHARMA INC. news stories on BioPortfolio along with dozens of ANTARES PHARMA INC. Clinical Trials and PubMed Articles about ANTARES PHARMA INC. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ANTARES PHARMA INC. Companies in our database. You can also find out about relevant ANTARES PHARMA INC. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record